Sign Up
Stories
Innovative Therapeutics Insights 2024
Share
Rising Protein Therapeutics Market Growt...
4D Molecular Therapeutics Raises $300 Mi...
89bio to Present pegozafermin for NASH a...
AB Science's Medical Breakthrough Webcas...
Overview
API
Reports from ResearchAndMarkets.com cover emerging therapeutics for Hemophilia B, positive results of zilebesiran for hypertension, IL-18 inhibitors, anti-integrin agents market analysis, and budesonide in treating primary biliary cholangitis.
Ask a question
How do collaborations impact the development of emerging therapeutics in healthcare?
How might market forecasts for budesonide in primary biliary cholangitis influence treatment approaches and patient outcomes?
What are the potential implications of the positive results of zilebesiran for hypertension treatment on future therapies?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage